Malachite Innovations, Inc. (MLCT)
| Market Cap | 15.44M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 51.45M |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 32,496 |
| Open | 0.000 |
| Previous Close | 0.300 |
| Day's Range | 0.270 - 0.325 |
| 52-Week Range | 0.050 - 0.850 |
| Beta | 4.15 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About MLCT
Malachite Innovations, Inc., together with its subsidiaries, provides health and wellness products in the United States. It offers a portfolio of approximately 100 novel cannabinoid-glycoside compounds created using its proprietary enzymatic bioprocessing technologies to develop treatments for chronic and debilitating conditions with an initial focus on inflammatory bowel disease. The company also engages in identifying, investing in, and repositioning environmental situations with a focus on technological innovations and eco-friendly solutions...
Financial Performance
Financial StatementsNews
Vitality Biopharma Announces Effective S-1 Registration Statement and DTC Eligibility
CLEVELAND, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTC Mkts: VBIO) (“Vitality” or the “Company”), an innovation-driven drug development company dedicated to unlocking the therapeuti...
3 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overa...